We have investigated the effects of oxidized low density lipoproteins (Ox-LDL) on aortic smooth muscle cell (SMC) proliferation and the biosynthesis of glycosphingolipids.
Watanabe heritable hyperlipidemic rabbits were exposed to Probucol (a potent antioxidant) it prevented the atherosclerotic process (Carew et al., 1987; Kita et al, 1987) .
Thus, although these lipoproteins could potentially cause injury to the aortic wall, very little is known regarding its biochemical mechanism of action. Our laboratory was the first to show that Ox-LDL stimulates the proliferation of aortic smooth muscle cells (Chatterjee, 1992) . In a subsequent study, we reported that exogenously supplied lactosylceramide (LacCer) may stimulate the proliferation of smooth muscle cells (Chatterjee, 1991) . Accordingly, we rationalized that one of the biochemical mechanisms in Ox-LDL mediated cell proliferation may involve activation of one or more of the metabolic enzymes in LacCer metabolism. Our studies reported here reveal that Ox-LDL specifically increases the activity of GalT-2, that in turn, produces LacCer and thus may contribute to the stimulation of aortic smooth muscle cell proliferation.
Results

Effects of oxidized LDL and various antibodies on the incorporation of pHJ-thymidine in aortic smooth muscle cells
Oxidized LDL exerted a concentration-dependent stimulation of thymidine incorporation in cultured cells (Figure  1 A) . Maximum stimulation of the incorporation of thymidine into cells was observed with about 10-20 /xg/ml Ox-LDL. This data indicate that at low concentrations oxidized LDL stimulates cell proliferation. In contrast, when cells were incubated with antibody against Ox-LDL, at various dilutions, it inhibited the proliferative effects in the cultured cells ( Figure IB) . However, incubation of cells with antibody against lactosylceramide did not have any effects on the oxidized LDL mediated incorporation of pH]-thymidine ( Figure 1C ). Finally, when the cells were incubated with antibody against GalT-2, we observed a marked inhibition in the proliferation of Ox-LDL mediated proliferation in cells ( Figure ID) . In sharp contrast, preincubation
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The role of Ox-LDL in atherosclerosis is becoming increasingly evident primarily because of the finding that such modified lipoproteins were found associated with the atherosclerotic plaques (Morton et al, 1986) . Second, when Anti-Gal T-2 Antibody ) were seeded in 96 well flat bottom trays. After 6 days of growth, fresh medium containing Ham's F-10 medium was added to one set of cultured dishes and increasing concentrations of Ox-LDL antibody was added. Cells were preincubated for about 1 h with the antibody. Then, Ox-LDL was added to cells incubated ±Ox-LDL antibody. After incubation for 22 h, [ 3 H]-thymidine (5 /xCi/ ml) was added to each well, incubation was continued for an additional 2 h. Subsequently, the incorporation of fHJ-thymidine into cells was measured as described previously (Chatterjee, 1992) . Each experiment was done in triplicate, and the data is shown from six individual wells. Ox-LDL (n.g/ml medium) Ox-LDL (|ig/ml medium) ) were grown in six well plastic trays for 6 days in full medium containing fetal calf serum. On the sixth day, the medium was changed and cells were incubated with Ham's F-10 medium and increasing concentrations of Ox-LDL (0-100 /xg/ml) and PH]-galactose or PH]-serine (5 ftCi/mi). After incubation for 24 h at 37°C, the medium was removed and cells were harvested with PBS. Subsequently, cells were extracted with organic solvents, the glycolipids were purified by silicic acid chromatography and then, they were subjected to separation by HPTLC; chloroform methanol-water 65:25:4 (v/v) was used as solvent. Gel areas corresponding to standard GlcCer and LacCer were scraped and the incorporation of radioactivity was measured. Suitable aliquots of cells were also subjected to measurements of protein according to Lowry's procedure (13) . Three such experiments were performed and the data of a representative experiment is shown here. A, Incorporation of [ 8 Time (hr) Fig. 4 . Effects of tune of incubation with Ox-LDL on the activity of GalT-2. Cells were grown as described in Figure 3 . Next, confluent cultures were incubated with Ox-LDL (10 pig/ml). At indicated intervals (0-8 hr) cells were harvested in cacodylate buffer (6.8). Subsequently, the activity of GalT-2 and GlcT-1 was measured as described in Materials and methods. GalT-2 activity (O), and GlcT-1 activity (A) (Havel ct aL, 1955) . The results are average values of two experiments analyzed in duplicate. The activity of glycosyltransferases varied 5% among experiments.
sylceramide was stimulated in the presence of low concentrations of Ox-LDL (5-10 /ig/ml) about 3.5-fold compared to control. As the concentration of Ox-LDL increased (50-100 /ig/ml), there was a substantial decrease in the incorporation of PHJ-serine into lactosylceramide, but at all concentrations of Ox-LDL used in this study the incorporation of PH]-serine into lactosylceramide was higher than control.
Effects of time of incubation with Ox-LDL on the activity of various glycosyltransferases and glycosidases
When cells were incubated with 10 yug of Ox-LDL/ml medium and the activity of GlcT-1 and GalT-2 was measured at various time points indicated in Figure 4 , we found that Ox-LDL did not stimulate the activity of GlcT-1 enzyme activity. In contrast, within 2 h of incubation of Ox-LDL with cells, we found about a 75% increase in the activity of GalT-2. Cells incubated with Ox-LDL up to 4-8 h had only moderately higher activities of GalT-2 than control. Ox-LDL did not alter the activity of GbOse 3 Cer 1 -» 4 galactosidase and LacCer 01 -> 4 galactosidase (data not shown).
Effects of Ox-LDL and LDL concentration and temperature of incubation on the activity of GalT-2
Ox-LDL exerted a concentration-dependent stimulation in the activity of GalT-2 in these cells ( Figure 5 ). In that, at low concentrations of Ox-LDL, we observed about a 40-60% stimulation in the activity of GalT-2. However, at high concentrations of Ox-LDL (100 Mg/ml), the activity of GalT-2 was unaffected compared to control. Incubation of cells with LDL ( Figure 5 ) did not stimulate the activity of GalT-2. In contrast, at high concentrations (25 /xg/ml medium) it suppressed the activity of GalT-2 on the order of about 70% compared to control.
Incubation of cells at 4°C with Ox-LDL did not increase the activity of GalT-2. For example, the GalT-2 values obtained from cells incubated with and without Ox-LDL at 4°C were on the order of 1.06 nmol/mg protein/2 h and 1.05 nmol/mg protein/2 hr, respectively.
Effects of Ox-LDL, D-PDMP, and L-PDMP on the activity of GalT-2
As shown in Figure 6 , D-PDMP exerted a concentrationdependent inhibition of the activity of GalT-2. In that, D-PDMP at 5 and 10 /u,M, decreased the activity of GalT-2 on the order of 50% and 40%, respectively, compared to control. Ox-LDL (10 Mg/ml) stimulated the activity of GalT-2 on the order of 140%. When cells were incubated with Ox-LDL plus D-PDMP, it compromised the stimulatory effects of Ox-LDL in these cells. Incubation of cells with L-PDMP stimulated the activity of GalT-2. When Ox-LDL and L-PDMP (5 (JLM) were added together to cells, the effects were additive in regard to the stimulation of GalT-2 activity. The addition of Ox-LDL and higher amounts of L-PDMP (10-20 /AM) sustained the stimulatory effects of GalT-2 activity in these cells ( Figure 5 ).
Effects of various antibodies on the activity of GalT-2 in cultured aortic smooth muscle cells
In these series of experiments, cells were incubated with Ox-LDL in the presence and absence of various antibodies against Ox-LDL, lactosylceramide, and GalT-2 (Table 1) . for 1 h at 37°C. Next, Ox-LDL (10 /*g protein/ml) was added and incubation was continued for an additional 2 hr. Subsequently, medium was removed and the cells were harvested in cacodylate buffer and GalT-2 activity was measured as described in Materials and methods. The control values for GalT-2 (100%) were 2.75 nmol 12 h/mg protein.
We found that whereas Ox-LDL stimulated the activity of the enzyme, this effect was compromised when cells were preincubated with antibody against Ox-LDL. However, antibody against Ox-LDL itself did not have any effects on GalT-2. When cells were incubated with antibody against lactosylceramide and Ox-LDL we found a significant stimulation in the activity of GalT-2. In contrast, antibody against GalT-2 by itself decreased the activity of GalT-2 in these cells on the order of about 50% compared to control. This antibody when added along with Ox-LDL compromised the effects of Ox-LDL in stimulating the activity of GalT-2. Cells were incubated for 1 hr with various antibodies (dilution 1 : 100). Next, Ox-LDL (10 ^ig/ml) was added. After incubation for 2 hr, cells were harvested and the activity of GaIT-2 was measured. The data represent standard deviation values from two separate experiments analyzed in duplicate.
Discussion
This study led to several significant findings. First, we found that Ox-LDL mediated stimulation of cell proliferation was compromised by the antibody against Ox-LDL or the antibody against the enzyme GalT-2. Second, Ox-LDL stimulated the endogenous synthesis of lactosylceramide, but not glucosylceramide from exogenously added radioactive precursors. Third, Ox-LDL specifically stimulated the activity of GalT-2 and this effect was time, concentration and temperature dependent. Fourth, Ox-LDL mediated stimulation of the activity of GalT-2 was compromised by an inhibitor of GalT-2, i.e., D-PDMP, and was stimulated by an activator of GalT-2, i.e., L-PDMP. Finally, the Ox-LDL mediated stimulation of activity of GalT-2 was compromised by antibody against GalT-2 and Ox-LDL itself, but not by antibody against lactosylceramide.
We have previously shown that Ox-LDL, particularly at low concentrations, can exert a concentration-dependent stimulation in the proliferation of aortic smooth muscle cells, (Chatterjee, 1992) . Subsequent studies from our laboratory revealed that lactosylceramide alone could stimulate the proliferation of these aortic smooth muscle cells (Chatterjee, 1991) . These findings are of great biological and clinical significance as Ox-LDL has been implicated in the pathogenesis of atherosclerosis. Moreover, recent studies from our laboratory reveal that both Ox-LDL and lactosylceramide are enriched in the atherosclerotic plaque in human subjects who have died of coronary artery disease (Chatterjee,S., Dey,S., Shi.W.Y., Thomas,K. and Hutchins,G., unpublished observations). Accordingly, we sought to understand biochemical mechanisms involved in the Ox-LDL mediated proliferation of aortic smooth muscle cells. Our studies reported in this manuscript reveal that indeed Ox-LDL at low concentrations can stimulate the proliferation of aortic smooth muscle cells. This phenomena ( Figure  7 ) may involve the binding of Ox-LDL to a putative cell surface receptor. Such a receptor has been recently described by Steinberg and co-workers (unpublished observations). This tenet is also supported with the evidence that the binding of Ox-LDL at 4°C does not stimulate the activity of GalT-2. Moreover, Ox-LDL did not impart any effect on the activity of GalT-2 in cell-free extracts. Taken together, these findings imply that Ox-LDL may be taken up by the cell surface receptor for Ox-LDL and delivered to a site accessible to GalT-2. Next, the activation of GalT-2, an enzyme that has been suggested to be present in the Golgi apparatus stimulates the synthesis of lactosylceramide from glucosylceramide. Finally, lactosylceramide via stimulating the phosphorylation of mitogen activated protein kinase (p 44 MAPK, ERK,) (Bhunia.A.K., Snowden.A., Han,H. and Chatterjee,S., unpublished observations) stimulates proliferation of the aortic smooth muscle cells. Several lines of investigations support the notion that the enzyme GalT-2 is involved in the signal transduction process in cell proliferation. In that, antibodies against Ox-LDL blocked the proliferation process, and inhibitors of glucosylceramide synthesis, lactosylceramide synthesis as well as the GalT-2 antibody directly inhibited both the cell proliferation as well as the activity of GalT-2. How antibody against GalT-2 impairs Ox-LDL mediated induction in cell proliferation is not understood from our studies. Particularly in view of the belief that most, if not all, GalT-2 is localized in the Golgi apparatus. This would imply that GalT-2 antibody would have to have access to the enzyme and therefore, must enter the cell. Alternatively, if that pool of GalT-2 involved in the signaling pathway is present on the cell surface, then the anti-GalT-2 antibody may have access and then, compromise the effects of Ox-LDL. In this regard, we have preliminary evidence that a significant amount of GalT-2 activity is present on the cell surface. Studies are in progress to elaborate this phenomena, further.
Since smooth muscle cells do not have detectable amounts of galactosylceramide, we infer that radioactivity derived from [ 3 H]-galactose is incorporated into glucosylceramide, and subsequently into lactosylceramide as a consequence of stimulation of GalT-2 antibody by Ox-LDL. Activators of GalT-2 such as L-PDMP stimulated both cell proliferation as well as the activity of GalT-2. Whether or not this reflects an additive increase in LacCer mass in cells is not known. Previously, Radin and co-workers showed that D-PDMP exerted a marked effect on cell proliferation in vitro and in vivo (Chatterjee et at., 1986; Radin et al., 1993) . Moreover, Inokuchi showed that L-PDMP stimulated the activity of GalT-2 in B-16 melanoma cells (Inokuchi,J.I., personal communication) Taken together, our data indicate that the activation of GalT-2 mediates the signal transduction process involved in Ox-LDL mediated proliferation of the aortic smooth muscle cells. We found that Ox-LDL mediated stimulation in the activity of GalT-2 ranged between 40-75% higher than control. This may be due batch to batch variation in Ox-LDL prepared from the LDL from different normalipidemic volunteers. In addition, this difference may be due to animal to animal variations as the primary cultures of aortic smooth muscle cells were derived from different rabbits. Nevertheless, in all of our experiments pursued over the last few years, Ox-LDL consistently stimulated the activity of GalT-2.
Recently, an epoxide derivative of glucosylceramide has been shown to specifically inhibit the endogenous synthesis of lactosylceramide (Zacharias et al., 1994) . Availability of such an inhibitor may be helpful in directly assessing the role of GalT-2 in the Ox-LDL mediated cell proliferation. Our laboratory is currently involved in the molecular cloning of the enzyme GalT-2. The availability of suitable
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GalT-2 cDNA probes for GalT-2 will help us understand the regulatory elements involved in Ox-LDL mediated activation of this enzyme and LDL mediated suppression of this enzyme in a variety of cultured cells. Such studies will hopefully lead to a better understanding of biochemical mechanisms involved in Ox-LDL mediated proliferation of aortic smooth muscle cells, a hallmark in the pathogenesis of atherosclerosis.
Materials and methods
Materials
Methyl-PH]-thymidine (specific activity 925 GBq/mmol), uridine diphosphate galactose (specific activity 12.2 GBq/mmol), d-PH]-galactose (specific activity 13 TBq/mmol), and l-PH]-serine (specific activity 1.07 TBq/ mmol), were purchased from Amersham, Inc. D-PDMP and L-PDMP were from Matreya, Inc. All other chemicals were purchased from Sigma Chemical Co. Aortic smooth muscle cells from New Zealand White rabbits were prepared as described previously (Ross, 1971) . Large batches of primary cultures were frozen and all experiments were done within passage 2-3. Typically, cells (X10 6 ) were seeded in P-100 plastic petri dishes and grown in minimum essential medium containing 10% fetal calf serum, nonessential amino acids, glutamine, penicillin, and streptomycin. Medium was changed on the 3rd and 6th day of cell growth. On the 7th day of cell growth, medium was removed and cells were incubated with serum free Ham's-F-10 medium for 2 h. Then various compounds were added, incubated, and processed as described below. For cell proliferation assay, cells (X10 3 ) were seeded in 96-well microtiter plates.
Preparation of LDL, oxidized LDL, and m I-Ox-LDL
Human plasma low density lipoproteins were prepared employing KBr gradient centrifugation (1.019-1.063 gm/dl) as described previously (Havel, el al., 1955) . Ox-LDL was prepared by dialyzing LDL against 5 MM CUSO 4 in sterile phosphate-buffered saline. LDL and Ox-LDL were characterized using physical-chemical criteria including electrophoretic migration on agarose gels, assays for thiobarbituric acid positive substance 310 and lysophosphatidylcholine, phosphatidylcholine levels as described (Chatterjee, 1992) . 12 I-LDL was prepared using modification of the procedure of McFarlane as described by us previously (Chatterjee, et al, 1988) .
123
I Ox-LDL was prepared from LDL by dialyzing against a solution of 5 utA copper sulfate in phosphate buffered saline. Freshly prepared Ox-LDL was used immediately in our experiments.
Incubation of cells with Ox-LDL and LDL
Following incubation of cells with Ham's F-10 medium, freshly prepared Ox-LDL and LDL (0-100 jtg protein/ml) was added and incubation carried out for 1 h. Cells were washed with PBS, harvested and stored frozen. In another set of dishes, cells were incubated with Ox-LDL (10 g protein/ml) for 0, 5 min, 10 min, 15 min, 30 min, 45 min, 60 min, 2 h, and 4 h. Next, cells were harvested in cacodylate buffer (pH 6.8) centrifuged and the pellets stored at -20°C. Such cell pellets were used for the measurement of various enzyme activities.
Preparation of antibodies
Polyclonal antibodies against human kidney UDP-galactose: glucosylceramide, 01 -» 4 galactosyltransferase (GalT-2), lactosylceramide and human plasma oxidized LDL were prepared against New Zealand White rabbits as descnbed previously (Chatterjee and Ghosh, 1989; Chatterjee, 1991) . Immunoglobulin G were prepared from the respective preimmune serum using ion exchange column chromatography (Econo-pac serum IgG purification kit, Bio-Rad, Richmond, CA). Next, the antibodies were immunoabsorbed against antigen and the monospecific polyclonal antibodies were eluted as described previously (Chatterjee and Ghosh, 1989) .
Assay for GalT-2, other glycosyltransferases, and glycohydrolases
Cells incubated with and without Ox-LDL, LDL, and other compounds were homogenized and suitable aliquots were used to measure the following activities: UDP-glucose: ceramide 01 -» 4 glucosyltransferase (GlcT-1), GalT-2, GbOse 3 Cer 1 -> 4 galactosidase, and LacCer 01 ^ 4 galactosidase. The procedures used for such assays have been described previously (Chatterjee, et aL, 1988) .
